[go: up one dir, main page]

US3920651A - Quaternary ammonium compounds - Google Patents

Quaternary ammonium compounds Download PDF

Info

Publication number
US3920651A
US3920651A US300233A US30023372A US3920651A US 3920651 A US3920651 A US 3920651A US 300233 A US300233 A US 300233A US 30023372 A US30023372 A US 30023372A US 3920651 A US3920651 A US 3920651A
Authority
US
United States
Prior art keywords
methyl
amino
propyl
pyrimidyl
ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US300233A
Inventor
Zoltan Ecsery
Nee Voros Judit Hermann
Nee Voros
Zoltan Torok
Peter Dvorcsak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of US3920651A publication Critical patent/US3920651A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Definitions

  • R is propyl
  • R is hydrogen, halogen, hydroxy, alkoxy or amino
  • R R and R are each aryl, aralkyl, heteroaralkyl or alkyl
  • Y is an acid or hydroxyl anion.
  • the compound has superior coccidiostatic properties.
  • CHRY I i R5 1 N R is an alkyl group having at least 2 carbon atoms
  • R is hydrogen, halogen, hydroxy, alkoxy or amino
  • R, R and R each can be aryl, aralkyl, heteroaralkyl or alkyl, whereby in the latter case two alkyl groups and the nitrogen atom, to which they are attached, may form a ring;
  • Y stands for an organic or inorganic acid residue or a hydroxyl anion, and acid addition salts of the compounds of that formula.
  • alkyl group relates to straight or branched chain radicals (preferably methyl, ethyl or propyl).
  • the symbols R", R and R may stand for identical or different alkyl groups. Two alkyl groups may form a heterocyclic ring with the nitrogen atom, to which they are attached (e.g. a pyrrole, pyridine, piperidine or preferably a pyrrolidine ring).
  • R", R and R may also be identical or different aryl groups (preferably phenyl), aralkyl (e.g. benzyl) or heteroalkyl.
  • R is an alkyl group and R R3, R, R and Y have the same meaning as stated above, and acid addition salts thereof, which comprises reacting a compound of the Formula II: F i
  • R, R and R can be an aryl, aralkyl, heteroaralkyl or alkyl group, whereby in the latter case two alkyl groups and the nitrogen atom, to which they are attached, may form a ring, with a compound of the Formula: R -x wherein R stands for an alkyl, aralkyl or heteroaralkyl group, with the proviso that R and/or R stand for a group of the Formula: and if R is methyl, the compound of the general Formula III is other than methyl iodide; X is an electron-attracting atom or atom group, and if desired replacing in the product thus obtained the anion by an other anion and if desired converting the compound thus obtained into an acid addition salt.
  • the group of the Formula IV may be present either in the starting materials of the Formula ll or in the compounds of the general Formula [II or in both of them.
  • X is an atom or group of atoms which makes the R group suitable for electrophilic attack by the electron attracting effect.
  • X can be halogen, a sulphonic acid radical or a group, which contains a quaternary nitrogen atom.
  • N-(2-alkyl-4-amino-5-pyrimidylmethyl)-N,N-dialkylamine, N-(2-alkyl-4-amino-5-pyrimidly-methyl)-pyrrolidine or a N-(2-alkyl-4-amino-5- pyrimidyl-methyl)-N-alkyl-aniline is reacted with an alkyl halide, alkyl sulphate, aralkyl halide or 2-alkyl-4- amino-S-pyrimidyl-methyl-halide.
  • Organic or inorganic solvents may be used, such as aliphatic or aromatic hydrocarbons (e.g. various petroleum-distillate fractions, benzene and homologues thereof), alcohols (e.g. methanol, ethanol, propanol aldehydes or ketones (e.g. acetone, methyl-ethyl-ketone), ethers (e.g. diethyl-ether, diisopropylether, tetrahydrofurane, dioxane), acids (e.g. acetic acid, propionic acid), esters (e.g.
  • aliphatic or aromatic hydrocarbons e.g. various petroleum-distillate fractions, benzene and homologues thereof
  • alcohols e.g. methanol, ethanol, propanol aldehydes or ketones (e.g. acetone, methyl-ethyl-ketone)
  • ethers e.g. diethyl-ether
  • reaction temperature depends on the reactivity of the starting materials ofthe Formulae II and "I. If X is a group having a strong reactivity, the reaction may be carried out at lO25C. If X is less reactive or the groups R, R and R decrease the reactivity of the tertiary amine due to a steric hindrance or an electron attracting effect, the reaction mixture should be heated to l50C.
  • the quaternary ammonium compounds thus obtained may be isolated preferably by filtering the product, which may be purified by crystallization, if necessary.
  • the products obtained may be converted into any suitable salts by dissolving the same in an excess of the desired acid and adding a solvent, in which the desired salt is insoluble or only slightly soluble (e.g. dioxane, acetone, tetrahydrofurane). Both the crude and the purified product may be used for salt formation.
  • aqueous potassium iodide solution is added to the aqueous solution of the product.
  • the anion may be replaced by an other halide anion or a sulphate, nitrate, phosphate or organic anion. These compounds may also be converted into their acid addition salts.
  • the startingmaterials used by the process of the present invention may be prepared according to the method described in J. Pharm. Soc. .lap., 76, 230-233 (1956).
  • the compounds of the present invention are useful starting materials in the preparation of known coccidiostatic and bactericidal agents and they also possess valuable therapeutic, and particulary coccidiostatic, activity.
  • a particular advantage of the compounds is that they are also active against strains which are resistant against known coccidiostatic agents.
  • EXAMPLE 1 3.88 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 17 ml of acetone, whereupon 1.24 ml of methyl iodide are added. After minutes the temperature rises to about 40C. The reaction mixture is allowed to stand overnight, whereupon the precipitated crystals are filtered and washed with acetone. Thus 5.13 g of N-(2-propyl-4-amino-5- pyrimidyl-methyl)-N,N,N-trimethyl-ammonium iodide are obtained. M.p. 16l 162C. On acidifying the ethanolic solution of the above product with concentrated hydroiodic acid, the iodide-hydroiodide salt is obtained. M.p. 213-215C.
  • EXAMPLE 2 35.4 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 120 ml of acetone and 45.6 g of an acetonic methyl bromide solution are added (the solution contains 17.4 g of methyl bromidel'. The reaction mixture is allowed to stand for some minutes, whereafter the temperature rises to 40C and the precipitation of a crystalline product begins. The reaction-mixture is allowed to stand overnight, whereupon the precipitated product is filtered off and washed with acetone.
  • EXAMPLE 3 38.8 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 194 ml of acetone containing 10.1 g of methyl chloride and the solution is allowed to stand in a sealed bomb tube for 65 hours at 25C, whereupon it is allowed to stand in a water bath having a temperature of 50C for 4 hours. After cooling, the bomb tube is opened, the crystals are filtered off and washed with acetone. 29.45 g of N-(2-propyl-4- amino-5-pyrirnidyl-methyl)-N,N,N-trimethylammonium chloride are obtained, which melts at 199201C. On evaporation the mother liquor 15.58 g of N-(2-propyl-4-amino-S-pyrimidyl-methyl)-N,N-
  • dimethylamine are recovered.
  • the product is dissolved in-anhydrous ethanol and the solution is acidified with ethanol containing hydrochloric acid to yield the chloride-hydrochloride salt, which melts at 20821 1C with decomposition.
  • EXAMPLE 4 1.5 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 7 ml of acetone and 0.71 ml of dimethyl sulphate are added. The temperature of the reaction mixture rises gradually to 4850C. The reaction mixture is allowed to stand overnight, the precipitated white crystals are filtered off and washed with acetone. Thus N-(2-propyl-4- amino-S-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-methosulphate are obtained, m.p. 158163C. The product is converted into the chloride-hydrochloride salt as described in Example 3. M.p. 208-211C.
  • EXAMPLE 5 9.6 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- pyrrolidine are dissolved in 16.2 ml of acetone and 2,2 g of methylene chloride are introduced into the solution from a bomb. The reaction mixture is allowed to stand in a sealed bomb tube over night, whereupon a yellow product precipitates, which recrystallizes on scratching. The melting point of the N-(2-propyl-4- amino-S-pyrimidyl-methyl)-N-methyl-pyrrolidiniumchloride amounts to 128-131C. The product is converted into the chloride-hydrochloride salt as described in Example 3. Melting point: 195-l96C.
  • EXAMPLE 7 2.56 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N-methyl-aniline are dissolved in 30 ml of acetone and 1.2 ml of benzyl chloride are added. The reaction mixture is allowed to stand in a sealed bomb tube over night. The precipitated white crystals are filtered off and washed with acetone. The melting point of the N- (2-propyl-4-amino-5-pyrimidyl-methyl )-N-methyl-N- benzyl-aniliniumchloride is 172C.
  • EXAMPLE 8 1 g of 2-propyl-4-amino-5-bromomethyl-pyrimidinedihydro-bromide and 1.48 g of N-(2-propyl-4-amino-5- pyrimidyl-methyl)-N,N-dimethylamine are dissolved in 10 ml of dimethylformamide at room temperature. After standing for 2 hours, the precipitation of crystals begins. The crystals are filtered off and washed with benzene. The melting point of the N,N-bis-(2-propyl-4- amino-S-pyrimidyl-methyl )-N,N-dimethyl-ammonium bromide amounts to 183184C. On recrystallization from anyydrous ethanol a product having a melting point of 184185C is obtained.
  • EXAMPLE 9 EXAMPLE l0 2 g of N-(2propyl-4-amino-5-pyrimidyl-methyl)- N,N,N-trimethyl-ammonium bromide are dissolved in ml of concentrated hydrochloric acid and 600 ml of acetone are added. The precipitated crystals are filtered off. The melting point of the chloride-hydrochloride salt thus obtained is 208-2l'lC.
  • EXAMPLE 12 2.13 g of N-( 2-propyl-4-chloro-S-pyrimidyl-methyl)- N,N-dimethylamine are reacted in 8 ml of acetone containing 0.95 g of methyl bromide at room temperature. The reaction mixture is allowed to stand for 24 hours, whereupon the precipitated crystals are filtered off and washed with acetone. Thus N-(2-propyl-4-chloro-5- pyrimidyl-methyl)-N,N,N-trimethyl-ammonium bromide are obtained.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A quaternary ammonium compound of the formula: WHEREIN R10 is propyl, R2 is hydrogen, halogen, hydroxy, alkoxy or amino, R3, R4 and R5 are each aryl, aralkyl, heteroaralkyl or alkyl and Y is an acid or hydroxyl anion. The compound has superior coccidiostatic properties.

Description

I United States Patent [1 1 Ecsery et al.
11] 3,920,651 Nov. 18, 1975 QUATERNARY AMMONIUM CONIPOUNDS [75] Inventors: Zoltn Ecsery; Judit Hermann nee Voros; Nee var-as; Zoltfin Torok, all of Budapest; Peter Dvorcss'lk, Ocsa, all of Hungary [22] Filed: Oct. 24, 1972 [21] Appl. No.: 300,233
[30] Foreign Application Priority Data Nov. 1, 1971 Hungary OE 1182 [52] U.S. Cl. 260/256.4 N; 2 60/256.4 C; 260/256.4 R, 424/251 [51] Int. CL? C07D 239/42 [58] Field of Search 260/256.4 N, 256.4 C, 260/256.4 R
[56] References Cited UNITED STATES PATENTS 2/1962 Rogers et a1 260/256.4 N 12/1964 Tull et al. 260/256.4 N
FOREIGN PATENTS OR APPLICATIONS 678,682 12/1964 ltaly 260/256.4 N
Primary ExaminerSherman D. Winters Attorney, Agent, or Firm-Karl F. Ross; Herbert Dubno 57 ABSTRACT A quaternary ammonium compound of the formula:
l 4 CH N R Y v N R 10 R N wherein R is propyl, R is hydrogen, halogen, hydroxy, alkoxy or amino, R R and R are each aryl, aralkyl, heteroaralkyl or alkyl and Y is an acid or hydroxyl anion. The compound has superior coccidiostatic properties.
6 Claims, 1 Drawing Figure US. Patent Nov. 18, 1975 QUATERNARY' AMMONIUM COMPOUNDS This invention is directed'to new quaternary ammonium compounds and a process for the preparation thereof. The compounds are useful in the preparation of pharmaceutically active compounds and also exhibit themselves coccidiostatic activity.
According to a feature of the present invention there are provided new compounds of the Formula:
2 4. CHRY I i R5 1 N R is an alkyl group having at least 2 carbon atoms;
R is hydrogen, halogen, hydroxy, alkoxy or amino;
R, R and R each can be aryl, aralkyl, heteroaralkyl or alkyl, whereby in the latter case two alkyl groups and the nitrogen atom, to which they are attached, may form a ring;
Y stands for an organic or inorganic acid residue or a hydroxyl anion, and acid addition salts of the compounds of that formula.
The term alkyl group relates to straight or branched chain radicals (preferably methyl, ethyl or propyl). The symbols R", R and R may stand for identical or different alkyl groups. Two alkyl groups may form a heterocyclic ring with the nitrogen atom, to which they are attached (e.g. a pyrrole, pyridine, piperidine or preferably a pyrrolidine ring). R", R and R may also be identical or different aryl groups (preferably phenyl), aralkyl (e.g. benzyl) or heteroalkyl.
According to a further feature of the present invention there is provided a process for the preparation of quaternary ammonium compounds of the general Formula:
wherein R is an alkyl group and R R3, R, R and Y have the same meaning as stated above, and acid addition salts thereof, which comprises reacting a compound of the Formula II: F i
wherein R, R and R can be an aryl, aralkyl, heteroaralkyl or alkyl group, whereby in the latter case two alkyl groups and the nitrogen atom, to which they are attached, may form a ring, with a compound of the Formula: R -x wherein R stands for an alkyl, aralkyl or heteroaralkyl group, with the proviso that R and/or R stand for a group of the Formula: and if R is methyl, the compound of the general Formula III is other than methyl iodide; X is an electron-attracting atom or atom group, and if desired replacing in the product thus obtained the anion by an other anion and if desired converting the compound thus obtained into an acid addition salt.
The group of the Formula IV (wherein R and R have the definitions stated above) may be present either in the starting materials of the Formula ll or in the compounds of the general Formula [II or in both of them. X is an atom or group of atoms which makes the R group suitable for electrophilic attack by the electron attracting effect. Thus X can be halogen, a sulphonic acid radical or a group, which contains a quaternary nitrogen atom.
Preferably a N-(2-alkyl-4-amino-5-pyrimidylmethyl)-N,N-dialkylamine, N-(2-alkyl-4-amino-5-pyrimidly-methyl)-pyrrolidine or a N-(2-alkyl-4-amino-5- pyrimidyl-methyl)-N-alkyl-aniline is reacted with an alkyl halide, alkyl sulphate, aralkyl halide or 2-alkyl-4- amino-S-pyrimidyl-methyl-halide.
One may also proceed by using starting materials in which R stands for hydrogen, halogen, hydroxy or alkoxy rather than for an amino group.
The reaction can be carried out in the presence of a solvent or without a solvent. Organic or inorganic solvents may be used, such as aliphatic or aromatic hydrocarbons (e.g. various petroleum-distillate fractions, benzene and homologues thereof), alcohols (e.g. methanol, ethanol, propanol aldehydes or ketones (e.g. acetone, methyl-ethyl-ketone), ethers (e.g. diethyl-ether, diisopropylether, tetrahydrofurane, dioxane), acids (e.g. acetic acid, propionic acid), esters (e.g. ethyl acetate, butyl acetate) or acid derivatives (e.g. dimethyl formamide). One may also proceed by using an excess of one of the reaction partners as a solvent or by carrying out the reaction without a solvent. The reaction temperature depends on the reactivity of the starting materials ofthe Formulae II and "I. If X is a group having a strong reactivity, the reaction may be carried out at lO25C. If X is less reactive or the groups R, R and R decrease the reactivity of the tertiary amine due to a steric hindrance or an electron attracting effect, the reaction mixture should be heated to l50C. The quaternary ammonium compounds thus obtained may be isolated preferably by filtering the product, which may be purified by crystallization, if necessary.
One may be also proceed by removing the solvent and isolating the desired product by means of crystallization. The products obtained may be converted into any suitable salts by dissolving the same in an excess of the desired acid and adding a solvent, in which the desired salt is insoluble or only slightly soluble (e.g. dioxane, acetone, tetrahydrofurane). Both the crude and the purified product may be used for salt formation. When iodide salts are to be prepared, an aqueous potassium iodide solution is added to the aqueous solution of the product.
In the product obtained, the anion may be replaced by an other halide anion or a sulphate, nitrate, phosphate or organic anion. These compounds may also be converted into their acid addition salts.
The startingmaterials used by the process of the present invention may be prepared according to the method described in J. Pharm. Soc. .lap., 76, 230-233 (1956).
As already mentioned above, the compounds of the present invention are useful starting materials in the preparation of known coccidiostatic and bactericidal agents and they also possess valuable therapeutic, and particulary coccidiostatic, activity. A particular advantage of the compounds is that they are also active against strains which are resistant against known coccidiostatic agents.
Further details of the present invention are disclosed in the following Examples.
EXAMPLE 1 3.88 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 17 ml of acetone, whereupon 1.24 ml of methyl iodide are added. After minutes the temperature rises to about 40C. The reaction mixture is allowed to stand overnight, whereupon the precipitated crystals are filtered and washed with acetone. Thus 5.13 g of N-(2-propyl-4-amino-5- pyrimidyl-methyl)-N,N,N-trimethyl-ammonium iodide are obtained. M.p. 16l 162C. On acidifying the ethanolic solution of the above product with concentrated hydroiodic acid, the iodide-hydroiodide salt is obtained. M.p. 213-215C.
EXAMPLE 2 35.4 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 120 ml of acetone and 45.6 g of an acetonic methyl bromide solution are added (the solution contains 17.4 g of methyl bromidel'. The reaction mixture is allowed to stand for some minutes, whereafter the temperature rises to 40C and the precipitation of a crystalline product begins. The reaction-mixture is allowed to stand overnight, whereupon the precipitated product is filtered off and washed with acetone. Thus 47.5 g of N-(2-propyl-4-amino-5- pyrimidylmethyl)-N,N,N-trimethyl-ammonium bromide are obtained. M.p. 244245C. The product is dissolved in anhydrous ethanol and the solution is acidified with 48% hydrobromic acid. The melting point of the bromide-hydrobromide salt thus obtained is 225228C.
EXAMPLE 3 38.8 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 194 ml of acetone containing 10.1 g of methyl chloride and the solution is allowed to stand in a sealed bomb tube for 65 hours at 25C, whereupon it is allowed to stand in a water bath having a temperature of 50C for 4 hours. After cooling, the bomb tube is opened, the crystals are filtered off and washed with acetone. 29.45 g of N-(2-propyl-4- amino-5-pyrirnidyl-methyl)-N,N,N-trimethylammonium chloride are obtained, which melts at 199201C. On evaporation the mother liquor 15.58 g of N-(2-propyl-4-amino-S-pyrimidyl-methyl)-N,N-
dimethylamine are recovered. The product is dissolved in-anhydrous ethanol and the solution is acidified with ethanol containing hydrochloric acid to yield the chloride-hydrochloride salt, which melts at 20821 1C with decomposition.
EXAMPLE 4 1.5 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethylamine are dissolved in 7 ml of acetone and 0.71 ml of dimethyl sulphate are added. The temperature of the reaction mixture rises gradually to 4850C. The reaction mixture is allowed to stand overnight, the precipitated white crystals are filtered off and washed with acetone. Thus N-(2-propyl-4- amino-S-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-methosulphate are obtained, m.p. 158163C. The product is converted into the chloride-hydrochloride salt as described in Example 3. M.p. 208-211C.
EXAMPLE 5 EXAMPLE 6 9.6 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- pyrrolidine are dissolved in 16.2 ml of acetone and 2,2 g of methylene chloride are introduced into the solution from a bomb. The reaction mixture is allowed to stand in a sealed bomb tube over night, whereupon a yellow product precipitates, which recrystallizes on scratching. The melting point of the N-(2-propyl-4- amino-S-pyrimidyl-methyl)-N-methyl-pyrrolidiniumchloride amounts to 128-131C. The product is converted into the chloride-hydrochloride salt as described in Example 3. Melting point: 195-l96C.
EXAMPLE 7 2.56 g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N-methyl-aniline are dissolved in 30 ml of acetone and 1.2 ml of benzyl chloride are added. The reaction mixture is allowed to stand in a sealed bomb tube over night. The precipitated white crystals are filtered off and washed with acetone. The melting point of the N- (2-propyl-4-amino-5-pyrimidyl-methyl )-N-methyl-N- benzyl-aniliniumchloride is 172C.
EXAMPLE 8 1 g of 2-propyl-4-amino-5-bromomethyl-pyrimidinedihydro-bromide and 1.48 g of N-(2-propyl-4-amino-5- pyrimidyl-methyl)-N,N-dimethylamine are dissolved in 10 ml of dimethylformamide at room temperature. After standing for 2 hours, the precipitation of crystals begins. The crystals are filtered off and washed with benzene. The melting point of the N,N-bis-(2-propyl-4- amino-S-pyrimidyl-methyl )-N,N-dimethyl-ammonium bromide amounts to 183184C. On recrystallization from anyydrous ethanol a product having a melting point of 184185C is obtained.
EXAMPLE 9 EXAMPLE l0 2 g of N-(2propyl-4-amino-5-pyrimidyl-methyl)- N,N,N-trimethyl-ammonium bromide are dissolved in ml of concentrated hydrochloric acid and 600 ml of acetone are added. The precipitated crystals are filtered off. The melting point of the chloride-hydrochloride salt thus obtained is 208-2l'lC.
EXAMPLE I l 2.5 g of N-(2-propyl-4-amino-S-pyrimidyl-methyl)- N,N,N-trimethyl-ammonium bromide-hydrobromide are dissolved in 5 ml of water, whereupon a solution of 2.5 g of potassium iodide and 2.5 ml of water is added. The precipitated crystals are filtered off. The melting point of the iodide-hydroiodide salt thus obtained is 2l3-215C.
EXAMPLE 12 2.13 g of N-( 2-propyl-4-chloro-S-pyrimidyl-methyl)- N,N-dimethylamine are reacted in 8 ml of acetone containing 0.95 g of methyl bromide at room temperature. The reaction mixture is allowed to stand for 24 hours, whereupon the precipitated crystals are filtered off and washed with acetone. Thus N-(2-propyl-4-chloro-5- pyrimidyl-methyl)-N,N,N-trimethyl-ammonium bromide are obtained.
EXAMPLE l3 1.66 g of N-(2-methyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethyl amine are reacted in 8 ml of acetone containing 0.95 g of methyl bromide at room temperature, whereupon the reaction mixture is allowed to stand for 16 hours. The precipitated crystals are filtered off and washed with acetone. Thus N-(2-methyl- 4-amino-5-pyrimidyl-methyl)-N,N,N-trimethylammonium bromide is obtained.
EXAMPLE 14 l g of N-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N,N-trimethyl-ammonium bromide-hydrobromide is heated with 2.1 g of N-(2-propyl-4-amino-5-pyrimidylmethyl)-N,N-dimethylamine for 4 hours at 135l40C. The reaction mixture is cooled and 5 ml of acetone are added. The precipitated crystals are filtered off, washed with anhydrous acetone and recrystallized from ethanol. The melting point of the N,N-bis- 6 (2-propyl-4-amino-5-pyrimidyl-methyl)-N,N-dimcthylammonium bromide is l84185C.
What we claim is: l. A quaternary ammonium compound of the formula 4 CH -NR Y 5 R R N wherein R is propyl R is amino or chloro, R R and R are methyl, ethyl, propyl, or benzyl; Y is an iodide, bromide or chloride anion, or the hydrogen iodide, hydrogen bromide or hydrogen chloride acid addition salt of said formula. 2. A compound selected from the following group: N-( 2-propyl-4-amino-5-pyrimidyl-methyl )-N,N,N-
trimethyl-ammonium-iodide; N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-bromide; N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-chloride; N-(2-propyl-4 amino-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-sulphate; N,N-bis-(2-propyl-4-amino-5-pyrimidyl-methyl)- N,N-dimethyl-ammonium-bromide; N-(2-propyl-4-chloro-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-bromide; N-(2-methyl-4-amino-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-bromide and; N,N-bis-(2-propyl-4-amino-5-pyrimidyl-methyl)- N.N-dimethyl-ammonium chloride. 3. The compound defined in claim 1 which consists of:
N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-iodide. 4. The compound defined in claim 1 which consists of:
N-(2-propyl-4-amino-S-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-bromide. 5. The compound defined in claim 1 which consists of:
N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-chloride. 6. The compound defined in claim 1 which consists of:
N-(2-propyl-4-chloro-S-pyrimidyl-methyl)-N,N,N-
trimethyl-ammonium-bromide.

Claims (6)

1. A QUARTERNARY AMMONIUM COMPOUND OF THE FORMULA
2. A compound selected from the following group: N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-iodide; N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-bromide; N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-chloride; N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-sulphate; N,N-bis-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N-dimethyl-ammonium-bromide; N-(2-propyl-4-chloro-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-bromide; N-(2-methyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-bromide and; N,N-bis-(2-propyl-4-amino-5-pyrimidyl-methyl)-N.N-dimethyl-ammonium chloride.
3. The compound defined in claim 1 which consists of: N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-iodide.
4. The compound defined in claim 1 which consists of: N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-bromide.
5. The compound defined in claim 1 which consists of: N-(2-propyl-4-amino-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-chloride.
6. The compound defined in claim 1 which consists of: N-(2-propyl-4-chloro-5-pyrimidyl-methyl)-N,N,N-trimethyl-ammonium-bromide.
US300233A 1971-11-01 1972-10-24 Quaternary ammonium compounds Expired - Lifetime US3920651A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI001182 1971-11-01

Publications (1)

Publication Number Publication Date
US3920651A true US3920651A (en) 1975-11-18

Family

ID=10994421

Family Applications (1)

Application Number Title Priority Date Filing Date
US300233A Expired - Lifetime US3920651A (en) 1971-11-01 1972-10-24 Quaternary ammonium compounds

Country Status (5)

Country Link
US (1) US3920651A (en)
CH (1) CH590242A5 (en)
DE (1) DE2251687A1 (en)
FR (1) FR2158347B1 (en)
SU (1) SU469241A3 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006143A (en) * 1974-04-09 1977-02-01 Merck & Co., Inc. Heterocyclic substituted pyrimidine compounds
US4028359A (en) * 1976-05-03 1977-06-07 Morton-Norwich Products, Inc. 2-Diethoxyethyl(dimethyl)(2-(2,4-diphenyl-5-pyrimidyl)-2-oxoethyl)ammonium bromide
US4552960A (en) * 1983-06-20 1985-11-12 Eli Lilly And Company Fungicidal amines
US4774251A (en) * 1984-06-18 1988-09-27 Eli Lilly And Company Method of inhibiting aromatase

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3020200A (en) * 1959-04-13 1962-02-06 Merck & Co Inc 1-(2-alkyl-4-amino-5-pyrimidinylmethyl)-alkyl-pyridinium quaternary salts for treating coccidiosis
US3161642A (en) * 1959-11-20 1964-12-15 Merck & Co Inc Preparation of pyrimidine derivatives by ether cleavage

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1566160A (en) * 1966-05-27 1969-05-09

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3020200A (en) * 1959-04-13 1962-02-06 Merck & Co Inc 1-(2-alkyl-4-amino-5-pyrimidinylmethyl)-alkyl-pyridinium quaternary salts for treating coccidiosis
US3161642A (en) * 1959-11-20 1964-12-15 Merck & Co Inc Preparation of pyrimidine derivatives by ether cleavage

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006143A (en) * 1974-04-09 1977-02-01 Merck & Co., Inc. Heterocyclic substituted pyrimidine compounds
US4028359A (en) * 1976-05-03 1977-06-07 Morton-Norwich Products, Inc. 2-Diethoxyethyl(dimethyl)(2-(2,4-diphenyl-5-pyrimidyl)-2-oxoethyl)ammonium bromide
US4552960A (en) * 1983-06-20 1985-11-12 Eli Lilly And Company Fungicidal amines
US4774251A (en) * 1984-06-18 1988-09-27 Eli Lilly And Company Method of inhibiting aromatase

Also Published As

Publication number Publication date
CH590242A5 (en) 1977-07-29
SU469241A3 (en) 1975-04-30
DE2251687A1 (en) 1973-05-10
FR2158347B1 (en) 1975-10-31
FR2158347A1 (en) 1973-06-15

Similar Documents

Publication Publication Date Title
US3920651A (en) Quaternary ammonium compounds
US4061647A (en) Thiazolidine derivatives
EP0009608B1 (en) N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
US2659732A (en) Quaternary ammonium salts of dialkyl aminoalkyl xanthene-9-carboxylates and the production thereof
US3103515A (en) Basic esters of i-benzoxacycloalkane-
US2621162A (en) J-propargyl-x-quinazolones and acid
US3426017A (en) Sulfonylurea compounds
US3828070A (en) Aminoethanesulfonyl derivatives and their production
PT80049B (en) PROCESS FOR THE PREPARATION OF 2-HYDROZINE-1,3-DIAZACYCYLOALQUIL-2-ENE HYDRO-HALET
US2970147A (en) 3-hydroxy-nu-(heterocyclic-ethyl)-morphinans
GB1563888A (en) Pyrimidine derivatives
US3321484A (en) Pyridinecarboxylic acid esters of cyclobutanediols
US4507308A (en) Analgesically or anti-inflammatory effective 4-quinolyl anthranilic acid derivatives
US2753345A (en) Substituted mercaptobenzoic acids and methods of preparing the same
US3725422A (en) New organic sulfur compounds and methods for their production
US2694706A (en) Alkenylamevoalkanoylphenotfflazine
US3244725A (en) 4, 5-diacyl-3-hydroxy-3-pyrrolin-2-ones
US3378592A (en) Process for the production of 3, 4-dihydroxybenzyloxyaminehydrobromide
KR880001105B1 (en) Method for preparing 1-benzyl-4- [4- (2-pyrimidinylamino) benzyl] -2,3-dioxopiperazin derivative
JPS6016931B2 (en) Method for producing substituted benzoic acid amide
EP0196910B1 (en) Benzo[a]phenazine derivatives
US5110945A (en) 1-azoniabicyclo[3.3.0]oct-1(5)-ene salt derivatives and process for the preparation of the same
CS199212B2 (en) Method of producing amides of pyridine-carboxylic acid
GB2160198A (en) Imidazolidines
US4010161A (en) Piperazinoethyl-N-(2,3-dimethyl-5-oxo-1-phenyl-3Δ-pyrazolin-4-yl)carbamates